Inpixon Reports 2020 Financial Results and Provides Business Update
PALO ALTO, Calif., March 25, 2021 /PRNewswire/ -- Inpixon (Nasdaq: INPX), the Indoor Intelligence™ company, today provided a business update...
PALO ALTO, Calif., March 25, 2021 /PRNewswire/ -- Inpixon (Nasdaq: INPX), the Indoor Intelligence™ company, today provided a business update...
- Completed $25 Million Strategic Financing; Extending Cash Runway into 2023- Accelerated Development of AL102 Desmoid Tumor Program into Phase...
Immunocore Provides Business Update and Reports Full Year 2020 Financial Results Breakthrough Therapy Designation granted by the FDA for tebentafusp...
Q4 2020 Net Revenue $20.6 Million, Highest Net Revenue Quarter Since Launch of Jeuveau®Pro Forma Cash Position of $57 Million...
BloombergTurkey’s Central Bank Chief May perhaps Have Little Time to Maintenance Believe in(Bloomberg) -- If the knowledge of Sahap Kavcioglu’s...
Conference Call on Thursday, March 25, 2021 at 4pm ETRESTON, Va., March 24, 2021 (GLOBE NEWSWIRE) -- Lightbridge Corporation (NASDAQ:...
BenzingaIf You Invested $1,000 In Bitcoin A single 12 months Ago, Here's How Considerably You'd Have NowBuyers who have owned...
(Provides comment, information)By Jonathan CableLONDON, March 24 (Reuters) - Euro zone company exercise unexpectedly grew this thirty day period, a...
Labcorp (NYSE: LH), a top existence sciences firm, right now issued the subsequent statement:Labcorp continues to make development executing our...
BloombergFight Amongst Commodities Giants and Shippers Leaves Seafarers Stuck(Bloomberg) -- A standoff between commodities giants and transport firms is prolonging...
BloombergU.S. Companies Shell out Penalties to Refinance as Inflation Fears Loom(Bloomberg) -- U.S. firms which include lodge chain Hilton Throughout...
50% of clients in the Section 2b Control examine have now been randomized regardless of COVID-19 disruptions in the trial...
BURLINGTON, N.C.--(Organization WIRE)--Mar 23, 2021--Labcorp (NYSE: LH), a major lifetime sciences corporation, today issued the subsequent assertion:Labcorp continues to make...
Entered into Exclusive License Agreement, with $7.5 Million Upfront License Fee and Potential to Receive up to an Additional $194.5...
- Initiated Phase 1 clinical trial for IDE397, a potential best-in-class MAT2A inhibitor for patients having tumors with MTAP-deletion- Planning...
FDA Type C meeting communications support plans to initiate Phase 2 in Q2 with NM-002 for short bowel syndrome (SBS)...
Conference call to discuss financial and operational results scheduled for Tuesday, March 23 at 8:00 a.m. U.S. Eastern TimeLaunched first...
(Provides particulars of letter, endeavours to re-stock medications)SAO PAULO, March 22 (Reuters) - Hundreds of Brazilian organization leaders and economists...